Large-scale testing (Phase 3)Active Not RecruitingNCT03911505
What this trial is testing
ZIP Study-OL Study of Safety, PK, Efficacy, PD, Immunogenicity of ATB200/AT2221 in Pediatrics Aged 0 to < 18 y.o. w/LOPD
Who this might be right for
Pompe Disease (Late-onset)
Amicus Therapeutics 21